latest update:
[TrialBase DB]

trial summary · NCT06336044

Pre-marketing Trial to Assess Safety and Efficacy of 'Volumizing Filler Based on Hyaluronic Acid and Recombinant Collagen'

"Clinical and Instrumental Evaluation of the Safety and Bio-revitalizing Effect on the Face of the Medical Device 'Volumizing Filler Based on Hyaluronic Acid and Recombinant Collagen'"

Trial record from the TrialBase DB dataset, status RECRUITING, condition Wrinkle, sponsored by Taumedika s.r.l.. Facts below are exported values from the current release, not inferred or edited prose.

registry NCT06336044phase —enrollment 40start 2026-11

Summary

The brief summary is the registry's published description, capped for length. Field definitions, types, and provenance rules are in the data dictionary.

Study to validate the safety and efficacy of the Hyaluronic Acid +Collagen filler 40 patients will undergo through 3 visits one to asses the health and apply the filler one after 4 weeks to check the results one after 16 weeks for the final check and results validation Safety assessed with analysis of the Adverse Events

Source record: https://clinicaltrials.gov/study/NCT06336044

Facts

registry idNCT06336044
primary registryclinicaltrials-gov
recruitment statusRECRUITING
phasenot reported
study typeINTERVENTIONAL
lead conditionWrinkle
sponsorTaumedika s.r.l.
sponsor classINDUSTRY
enrollment40
start date2026-11
primary completion2027-02
completion2027-04
results postednot reported

Conditions

  • Wrinkle
  • Scar
  • Laxity; Skin

Interventions

  • Karisma

Countries

  • Italy

Intervention types: DEVICE

Work with this record